Showing results (151-160 of 219) with videos related to
Sort By:
Pageof 22
European Journal of Immunology|January 3, 2013
Cytomegalovirus-specific T cells are detectable in early childhood and allow assignment of the infection status in children with passive maternal antibodiesMarion Ritter, Tina Schmidt, Jan Dirks, et al.AIDS (London, England)|February 4, 2012
Pathogen prevalence may determine maintenance of antigen-specific T-cell responses in HIV-infected individualsAlexandra Schuetz, Jan Dirks, Urban Sester, et al.Journal for Immunotherapy of Cancer|July 18, 2019
miR-34a as hub of T cell regulation networksMartin Hart, Barbara Walch-Rückheim, Lena Krammes, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2005
Plasma HIV-1 RNA decline within the first two weeks of treatment is comparable for nevirapine, efavirenz, or both drugs combined and is not predictive of long-term virologic efficacy: A 2NN substudyFrank van Leth, Casper B Huisamen, Roberto Badaro, et al.The Journal of Infectious Diseases|October 17, 2006
Epstein-Barr virus infects B and non-B lymphocytes in HIV-1-infected children and adolescentsVincent Bekker, Henriëtte Scherpbier, Marcel Beld, et al.The Journal of Antimicrobial Chemotherapy|February 1, 2017
Antimicrobial resistance in uropathogens and appropriateness of empirical treatment: a population-based surveillance study in IndonesiaAdhi Kristianto Sugianli, Franciscus Ginting, R Lia Kusumawati, et al.NPJ Vaccines|February 7, 2024
Potent induction of humoral and cellular immunity after bivalent BA.4/5 mRNA vaccination in dialysis patientsSaskia Bronder, Janine Mihm, Rebecca Urschel, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 24, 2022
NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimensFranziska Hielscher, Tina Schmidt, Verena Klemis, et al.Frontiers in Oncology|September 28, 2020
Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After RituximabIgor Kos, Benedikt Balensiefer, Sophie Roth, et al.Pathogens & Immunity|March 10, 2025
A Year in Review on Tuberculosis and Non-tuberculous Mycobacteria Disease: A 2025 Update for Clinicians and ScientistsChristoph Lange, Graham Bothamley, Gunar Günther, et al.Pageof 22